17-alpha-Hydroxyprogesterone
The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Tocilizumab.
Abatacept
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Abatacept.
Abemaciclib
The serum concentration of Abemaciclib can be decreased when it is combined with Tocilizumab.
Advertisement
Abiraterone
The serum concentration of Abiraterone can be decreased when it is combined with Tocilizumab.
Acenocoumarol
The serum concentration of Acenocoumarol can be decreased when it is combined with Tocilizumab.
Acetaminophen
The serum concentration of Acetaminophen can be decreased when it is combined with Tocilizumab.
Advertisement
Adalimumab
Tocilizumab may increase the immunosuppressive activities of Adalimumab.
Ado-Trastuzumab Emtansine
The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Tocilizumab.
Albendazole
The serum concentration of Albendazole can be decreased when it is combined with Tocilizumab.
Advertisement
Alclometasone
The serum concentration of Alclometasone can be decreased when it is combined with Tocilizumab.
Alfentanil
The serum concentration of Alfentanil can be decreased when it is combined with Tocilizumab.
Alfuzosin
The serum concentration of Alfuzosin can be decreased when it is combined with Tocilizumab.
Aliskiren
The serum concentration of Aliskiren can be decreased when it is combined with Tocilizumab.
Allylestrenol
The serum concentration of Allylestrenol can be decreased when it is combined with Tocilizumab.
Almotriptan
The serum concentration of Almotriptan can be decreased when it is combined with Tocilizumab.
Alogliptin
The serum concentration of Alogliptin can be decreased when it is combined with Tocilizumab.
Alosetron
The serum concentration of Alosetron can be decreased when it is combined with Tocilizumab.
alpha-Tocopherol Acetate
The serum concentration of alpha-Tocopherol acetate can be decreased when it is combined with Tocilizumab.
Alprazolam
The serum concentration of Alprazolam can be decreased when it is combined with Tocilizumab.
Ambrisentan
The serum concentration of Ambrisentan can be decreased when it is combined with Tocilizumab.
Ambroxol
The serum concentration of Ambroxol can be decreased when it is combined with Tocilizumab.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Tocilizumab.
Aminopyrine
The serum concentration of Aminophenazone can be decreased when it is combined with Tocilizumab.
Amiodarone
The serum concentration of Amiodarone can be decreased when it is combined with Tocilizumab.
Amitriptyline
The serum concentration of Amitriptyline can be decreased when it is combined with Tocilizumab.
Amlodipine
The serum concentration of Amlodipine can be decreased when it is combined with Tocilizumab.
Amprenavir
The serum concentration of Amprenavir can be decreased when it is combined with Tocilizumab.
Anakinra
The risk or severity of adverse effects can be increased when Anakinra is combined with Tocilizumab.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Tocilizumab.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Anthrax immune globulin human.
Antipyrine
The serum concentration of Antipyrine can be decreased when it is combined with Tocilizumab.
Apalutamide
The serum concentration of Apalutamide can be decreased when it is combined with Tocilizumab.
Apixaban
The serum concentration of Apixaban can be decreased when it is combined with Tocilizumab.
Apremilast
The serum concentration of Apremilast can be decreased when it is combined with Tocilizumab.
Aprepitant
The serum concentration of Aprepitant can be decreased when it is combined with Tocilizumab.
Argatroban
The serum concentration of Argatroban can be decreased when it is combined with Tocilizumab.
Argatroban Anhydrous
The serum concentration of Argatroban can be decreased when it is combined with Tocilizumab.
Aripiprazole
The serum concentration of Aripiprazole can be decreased when it is combined with Tocilizumab.
Artemether
The serum concentration of Artemether can be decreased when it is combined with Tocilizumab.
Asenapine
The serum concentration of Asenapine can be decreased when it is combined with Tocilizumab.
Astemizole
The serum concentration of Astemizole can be decreased when it is combined with Tocilizumab.
Asunaprevir
The serum concentration of Asunaprevir can be decreased when it is combined with Tocilizumab.
Atazanavir
The serum concentration of Atazanavir can be decreased when it is combined with Tocilizumab.
Atorvastatin
The serum concentration of Atorvastatin can be decreased when it is combined with Tocilizumab.
Avanafil
The serum concentration of Avanafil can be decreased when it is combined with Tocilizumab.
Avatrombopag
The serum concentration of Avatrombopag can be decreased when it is combined with Tocilizumab.
Axitinib
The serum concentration of Axitinib can be decreased when it is combined with Tocilizumab.
Azelastine
The serum concentration of Azelastine can be decreased when it is combined with Tocilizumab.
Azithromycin
The serum concentration of Azithromycin can be decreased when it is combined with Tocilizumab.
Baricitinib
The serum concentration of Baricitinib can be decreased when it is combined with Tocilizumab.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Tocilizumab.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bacillus calmette-guerin substrain tice live antigen.
Bedaquiline
The serum concentration of Bedaquiline can be decreased when it is combined with Tocilizumab.
Belimumab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Belimumab.
Benzphetamine
The serum concentration of Benzphetamine can be decreased when it is combined with Tocilizumab.
Benzyl Alcohol
The serum concentration of Benzyl alcohol can be decreased when it is combined with Tocilizumab.
Bexarotene
The serum concentration of Bexarotene can be decreased when it is combined with Tocilizumab.
Bezafibrate
The serum concentration of Bezafibrate can be decreased when it is combined with Tocilizumab.
Bicalutamide
The serum concentration of Bicalutamide can be decreased when it is combined with Tocilizumab.
Bictegravir
The serum concentration of Bictegravir can be decreased when it is combined with Tocilizumab.
Bioallethrin
The serum concentration of Bioallethrin can be decreased when it is combined with Tocilizumab.
Bisoprolol
The serum concentration of Bisoprolol can be decreased when it is combined with Tocilizumab.
Boceprevir
The serum concentration of Boceprevir can be decreased when it is combined with Tocilizumab.
Bortezomib
The serum concentration of Bortezomib can be decreased when it is combined with Tocilizumab.
Bosentan
The serum concentration of Bosentan can be decreased when it is combined with Tocilizumab.
Bosentan Anhydrous
The serum concentration of Bosentan can be decreased when it is combined with Tocilizumab.
Bosutinib
The serum concentration of Bosutinib can be decreased when it is combined with Tocilizumab.
Bosutinib monohydrate
The serum concentration of Bosutinib can be decreased when it is combined with Tocilizumab.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be decreased when it is combined with Tocilizumab.
Brexpiprazole
The serum concentration of Brexpiprazole can be decreased when it is combined with Tocilizumab.
Brigatinib
The serum concentration of Brigatinib can be decreased when it is combined with Tocilizumab.
Brinzolamide
The serum concentration of Brinzolamide can be decreased when it is combined with Tocilizumab.
Brivaracetam
The serum concentration of Brivaracetam can be decreased when it is combined with Tocilizumab.
Bromazepam
The serum concentration of Bromazepam can be decreased when it is combined with Tocilizumab.
Bromocriptine
The serum concentration of Bromocriptine can be decreased when it is combined with Tocilizumab.
Brompheniramine
The serum concentration of Brompheniramine can be decreased when it is combined with Tocilizumab.
Budesonide
The serum concentration of Budesonide can be decreased when it is combined with Tocilizumab.
Bupivacaine
The serum concentration of Bupivacaine can be decreased when it is combined with Tocilizumab.
Buprenorphine
The serum concentration of Buprenorphine can be decreased when it is combined with Tocilizumab.
Bupropion
The serum concentration of Bupropion can be decreased when it is combined with Tocilizumab.
Buspirone
The serum concentration of Buspirone can be decreased when it is combined with Tocilizumab.
Busulfan
The serum concentration of Busulfan can be decreased when it is combined with Tocilizumab.
Cabazitaxel
The serum concentration of Cabazitaxel can be decreased when it is combined with Tocilizumab.
Cabergoline
The serum concentration of Cabergoline can be decreased when it is combined with Tocilizumab.
Cabozantinib
The serum concentration of Cabozantinib can be decreased when it is combined with Tocilizumab.
Caffeine
The serum concentration of Caffeine can be decreased when it is combined with Tocilizumab.
Calcitriol
The serum concentration of Calcitriol can be decreased when it is combined with Tocilizumab.
Canagliflozin
The serum concentration of Canagliflozin can be decreased when it is combined with Tocilizumab.
Canagliflozin Anhydrous
The serum concentration of Canagliflozin can be decreased when it is combined with Tocilizumab.
Cannabidiol
The serum concentration of Cannabidiol can be decreased when it is combined with Tocilizumab.
Cannavis sativa susp. indica top extract
The serum concentration of Medical Cannabis can be decreased when it is combined with Tocilizumab.
Carbamazepine
The serum concentration of Carbamazepine can be decreased when it is combined with Tocilizumab.
Carbinoxamine
The serum concentration of Carbinoxamine can be decreased when it is combined with Tocilizumab.
Cariprazine
The serum concentration of Cariprazine can be decreased when it is combined with Tocilizumab.
Carvedilol
The serum concentration of Carvedilol can be decreased when it is combined with Tocilizumab.
Celecoxib
The serum concentration of Celecoxib can be decreased when it is combined with Tocilizumab.
Celiprolol
The serum concentration of Celiprolol can be decreased when it is combined with Tocilizumab.
Cephalexin
The serum concentration of Cephalexin can be decreased when it is combined with Tocilizumab.
CEPHALEXIN ANHYDROUS
The serum concentration of Cephalexin can be decreased when it is combined with Tocilizumab.
Cerivastatin
The serum concentration of Cerivastatin can be decreased when it is combined with Tocilizumab.
Certolizumab Pegol
Tocilizumab may increase the immunosuppressive activities of Certolizumab pegol.
Cevimeline
The serum concentration of Cevimeline can be decreased when it is combined with Tocilizumab.
Chenodeoxycholate
The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Tocilizumab.
Chenodeoxycholic Acid
The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Tocilizumab.
Chlordiazepoxide
The serum concentration of Chlordiazepoxide can be decreased when it is combined with Tocilizumab.
Chlormethiazole
The serum concentration of clomethiazole can be decreased when it is combined with Tocilizumab.
Chloroquine
The serum concentration of Chloroquine can be decreased when it is combined with Tocilizumab.
Chlorpheniramine
The serum concentration of Chlorphenamine can be decreased when it is combined with Tocilizumab.
CHLORPHENIRAMINE POLISTIREX
The serum concentration of Chlorphenamine can be decreased when it is combined with Tocilizumab.
Chlorpromazine
The serum concentration of Chlorpromazine can be decreased when it is combined with Tocilizumab.
Chlorzoxazone
The serum concentration of Chlorzoxazone can be decreased when it is combined with Tocilizumab.
Cholecalciferol
The serum concentration of Cholecalciferol can be decreased when it is combined with Tocilizumab.
Ciclesonide
The serum concentration of Ciclesonide can be decreased when it is combined with Tocilizumab.
Cilostazol
The serum concentration of Cilostazol can be decreased when it is combined with Tocilizumab.
Cinacalcet
The serum concentration of Cinacalcet can be decreased when it is combined with Tocilizumab.
Cisapride
The serum concentration of Cisapride can be decreased when it is combined with Tocilizumab.
Citalopram
The serum concentration of Citalopram can be decreased when it is combined with Tocilizumab.
Clarithromycin
The serum concentration of Clarithromycin can be decreased when it is combined with Tocilizumab.
Clindamycin
The serum concentration of Clindamycin can be decreased when it is combined with Tocilizumab.
Clobazam
The serum concentration of Clobazam can be decreased when it is combined with Tocilizumab.
Clofazimine
The serum concentration of Clofazimine can be decreased when it is combined with Tocilizumab.
Clofezone
The serum concentration of Rabeprazole can be decreased when it is combined with Tocilizumab.
Clofibrate
The serum concentration of Clofibrate can be decreased when it is combined with Tocilizumab.
Clomipramine
The serum concentration of Clomipramine can be decreased when it is combined with Tocilizumab.
Clonazepam
The serum concentration of Clonazepam can be decreased when it is combined with Tocilizumab.
Clonidine
The serum concentration of Clonidine can be decreased when it is combined with Tocilizumab.
Clopidogrel
The serum concentration of Clopidogrel can be decreased when it is combined with Tocilizumab.
Clorazepate
The serum concentration of Clorazepate can be decreased when it is combined with Tocilizumab.
CLORAZEPIC ACID
The serum concentration of Clorazepate can be decreased when it is combined with Tocilizumab.
Clotiazepam
The serum concentration of Clotiazepam can be decreased when it is combined with Tocilizumab.
Clozapine
The serum concentration of Clozapine can be decreased when it is combined with Tocilizumab.
Cocaine
The serum concentration of Cocaine can be decreased when it is combined with Tocilizumab.
Codeine
The serum concentration of Codeine can be decreased when it is combined with Tocilizumab.
Codeine Anhydrous
The serum concentration of Codeine can be decreased when it is combined with Tocilizumab.
CODEINE POLISTIREX
The serum concentration of Codeine can be decreased when it is combined with Tocilizumab.
Colchicine
The serum concentration of Colchicine can be decreased when it is combined with Tocilizumab.
Conivaptan
The serum concentration of Conivaptan can be decreased when it is combined with Tocilizumab.
Copanlisib
The serum concentration of Copanlisib can be decreased when it is combined with Tocilizumab.
Cortisone Acetate
The serum concentration of Cortisone acetate can be decreased when it is combined with Tocilizumab.
Crizotinib
The serum concentration of Crizotinib can be decreased when it is combined with Tocilizumab.
Cyclobenzaprine
The serum concentration of Cyclobenzaprine can be decreased when it is combined with Tocilizumab.
Cyclophosphamide
The serum concentration of Cyclophosphamide can be decreased when it is combined with Tocilizumab.
Cyclophosphamide Anhydrous
The serum concentration of Cyclophosphamide can be decreased when it is combined with Tocilizumab.
Cyclosporine
The serum concentration of Cyclosporine can be decreased when it is combined with Tocilizumab.
Cytarabine
The serum concentration of Cytarabine can be decreased when it is combined with Tocilizumab.
Dabrafenib
The serum concentration of Dabrafenib can be decreased when it is combined with Tocilizumab.
Daclatasvir
The serum concentration of Daclatasvir can be decreased when it is combined with Tocilizumab.
Dantrolene
The serum concentration of Dantrolene can be decreased when it is combined with Tocilizumab.
Dapagliflozin
The serum concentration of Dapagliflozin can be decreased when it is combined with Tocilizumab.
Dapsone
The serum concentration of Dapsone can be decreased when it is combined with Tocilizumab.
Darifenacin
The serum concentration of Darifenacin can be decreased when it is combined with Tocilizumab.
Darunavir
The serum concentration of Darunavir can be decreased when it is combined with Tocilizumab.
Dasabuvir
The serum concentration of Dasabuvir can be decreased when it is combined with Tocilizumab.
Dasatinib
The serum concentration of Dasatinib can be decreased when it is combined with Tocilizumab.
Dasatinib Anhydrous
The serum concentration of Dasatinib can be decreased when it is combined with Tocilizumab.
Daunorubicin
The serum concentration of Daunorubicin can be decreased when it is combined with Tocilizumab.
Deflazacort
The serum concentration of Deflazacort can be decreased when it is combined with Tocilizumab.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Tocilizumab.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Tocilizumab.
Desvenlafaxine
The serum concentration of Desvenlafaxine can be decreased when it is combined with Tocilizumab.
Deutetrabenazine
The serum concentration of Deutetrabenazine can be decreased when it is combined with Tocilizumab.
Dexamethasone
The serum concentration of Dexamethasone can be decreased when it is combined with Tocilizumab.
Dexchlorpheniramine maleate
The serum concentration of Dexchlorpheniramine maleate can be decreased when it is combined with Tocilizumab.
Dexlansoprazole
The serum concentration of Dexlansoprazole can be decreased when it is combined with Tocilizumab.
Dextromethorphan
The serum concentration of Dextromethorphan can be decreased when it is combined with Tocilizumab.
Diazepam
The serum concentration of Diazepam can be decreased when it is combined with Tocilizumab.
Diclofenac
The serum concentration of Diclofenac can be decreased when it is combined with Tocilizumab.
Dienogest
The serum concentration of Dienogest can be decreased when it is combined with Tocilizumab.
Digitoxin
The serum concentration of Digitoxin can be decreased when it is combined with Tocilizumab.
Digoxin
The serum concentration of Digoxin can be decreased when it is combined with Tocilizumab.
Dihydro-alpha-ergocryptine
The serum concentration of Dihydro-alpha-ergocryptine can be decreased when it is combined with Tocilizumab.
Dihydrocodeine
The serum concentration of Dihydrocodeine can be decreased when it is combined with Tocilizumab.
Dihydroergocryptine
The serum concentration of Dihydro-alpha-ergocryptine can be decreased when it is combined with Tocilizumab.
Dihydroergotamine
The serum concentration of Dihydroergotamine can be decreased when it is combined with Tocilizumab.
Diltiazem
The serum concentration of Diltiazem can be decreased when it is combined with Tocilizumab.
Disopyramide
The serum concentration of Disopyramide can be decreased when it is combined with Tocilizumab.
Disulfiram
The serum concentration of Disulfiram can be decreased when it is combined with Tocilizumab.
Dl-Alpha Tocopheryl Acetate
The serum concentration of alpha-Tocopherol acetate can be decreased when it is combined with Tocilizumab.
Docetaxel
The serum concentration of Docetaxel can be decreased when it is combined with Tocilizumab.
DOCETAXEL ANHYDROUS
The serum concentration of Docetaxel can be decreased when it is combined with Tocilizumab.
Dofetilide
The serum concentration of Dofetilide can be decreased when it is combined with Tocilizumab.
Dolasetron
The serum concentration of Dolasetron can be decreased when it is combined with Tocilizumab.
Domperidone
The serum concentration of Domperidone can be decreased when it is combined with Tocilizumab.
Donepezil
The serum concentration of Donepezil can be decreased when it is combined with Tocilizumab.
Dorzolamide
The serum concentration of Dorzolamide can be decreased when it is combined with Tocilizumab.
Doxepin
The serum concentration of Doxepin can be decreased when it is combined with Tocilizumab.
Doxorubicin
The serum concentration of Doxorubicin can be decreased when it is combined with Tocilizumab.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be decreased when it is combined with Tocilizumab.
Dronedarone
The serum concentration of Dronedarone can be decreased when it is combined with Tocilizumab.
Dutasteride
The serum concentration of Dutasteride can be decreased when it is combined with Tocilizumab.
Efavirenz
The serum concentration of Efavirenz can be decreased when it is combined with Tocilizumab.
Elbasvir
The serum concentration of Elbasvir can be decreased when it is combined with Tocilizumab.
Eletriptan
The serum concentration of Eletriptan can be decreased when it is combined with Tocilizumab.
Eliglustat
The serum concentration of Eliglustat can be decreased when it is combined with Tocilizumab.
Elvitegravir
The serum concentration of Elvitegravir can be decreased when it is combined with Tocilizumab.
Enalapril
The serum concentration of Enalapril can be decreased when it is combined with Tocilizumab.
Enasidenib
The serum concentration of Enasidenib can be decreased when it is combined with Tocilizumab.
Enzalutamide
The serum concentration of Enzalutamide can be decreased when it is combined with Tocilizumab.
Epinastine
The serum concentration of Epinastine can be decreased when it is combined with Tocilizumab.
Eplerenone
The serum concentration of Eplerenone can be decreased when it is combined with Tocilizumab.
Ergocalciferol
The serum concentration of Ergocalciferol can be decreased when it is combined with Tocilizumab.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be decreased when it is combined with Tocilizumab.
Ergonovine
The serum concentration of Ergonovine can be decreased when it is combined with Tocilizumab.
Ergotamine
The serum concentration of Ergotamine can be decreased when it is combined with Tocilizumab.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Tocilizumab.
Erythromycin
The serum concentration of Erythromycin can be decreased when it is combined with Tocilizumab.
Escitalopram
The serum concentration of Escitalopram can be decreased when it is combined with Tocilizumab.
Esomeprazole
The serum concentration of Esomeprazole can be decreased when it is combined with Tocilizumab.
Estazolam
The serum concentration of Estazolam can be decreased when it is combined with Tocilizumab.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Tocilizumab.
Estradiol 3-Benzoate
The serum concentration of Estradiol benzoate can be decreased when it is combined with Tocilizumab.
Estradiol acetate
The serum concentration of Estradiol acetate can be decreased when it is combined with Tocilizumab.
Estradiol Cypionate
The serum concentration of Estradiol cypionate can be decreased when it is combined with Tocilizumab.
Estradiol Valerate
The serum concentration of Estradiol valerate can be decreased when it is combined with Tocilizumab.
Estramustine
The serum concentration of Estramustine can be decreased when it is combined with Tocilizumab.
Estrogens, Conjugated (USP)
The serum concentration of Conjugated estrogens can be decreased when it is combined with Tocilizumab.
Estrogens, Esterified (USP)
The serum concentration of Estrogens, esterified can be decreased when it is combined with Tocilizumab.
Estrone
The serum concentration of Estrone can be decreased when it is combined with Tocilizumab.
Eszopiclone
The serum concentration of Eszopiclone can be decreased when it is combined with Tocilizumab.
Etanercept
Tocilizumab may increase the immunosuppressive activities of Etanercept.
Ethanol
The serum concentration of Ethanol can be decreased when it is combined with Tocilizumab.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Tocilizumab.
Ethosuximide
The serum concentration of Ethosuximide can be decreased when it is combined with Tocilizumab.
Ethylmorphine
The serum concentration of Ethylmorphine can be decreased when it is combined with Tocilizumab.
Etonogestrel
The serum concentration of Etonogestrel can be decreased when it is combined with Tocilizumab.
Etoposide
The serum concentration of Etoposide can be decreased when it is combined with Tocilizumab.
Etoricoxib
The serum concentration of Etoricoxib can be decreased when it is combined with Tocilizumab.
Etravirine
The serum concentration of Etravirine can be decreased when it is combined with Tocilizumab.
Everolimus
The serum concentration of Everolimus can be decreased when it is combined with Tocilizumab.
Exemestane
The serum concentration of Exemestane can be decreased when it is combined with Tocilizumab.
Famciclovir
The serum concentration of Famciclovir can be decreased when it is combined with Tocilizumab.
Felbamate
The serum concentration of Felbamate can be decreased when it is combined with Tocilizumab.
Felodipine
The serum concentration of Felodipine can be decreased when it is combined with Tocilizumab.
Fenofibrate
The serum concentration of Fenofibrate can be decreased when it is combined with Tocilizumab.
Fentanyl
The serum concentration of Fentanyl can be decreased when it is combined with Tocilizumab.
Fesoterodine
The serum concentration of Fesoterodine can be decreased when it is combined with Tocilizumab.
Finasteride
The serum concentration of Finasteride can be decreased when it is combined with Tocilizumab.
Fingolimod
Tocilizumab may increase the immunosuppressive activities of Fingolimod.
Flibanserin
The serum concentration of Flibanserin can be decreased when it is combined with Tocilizumab.
Flunisolide
The serum concentration of Flunisolide can be decreased when it is combined with Tocilizumab.
Flunisolide Anhydrous (obsolete)
The serum concentration of Flunisolide can be decreased when it is combined with Tocilizumab.
Flunitrazepam
The serum concentration of Flunitrazepam can be decreased when it is combined with Tocilizumab.
Fluorometholone
The serum concentration of Fluorometholone can be decreased when it is combined with Tocilizumab.
Fluoxetine
The serum concentration of Fluoxetine can be decreased when it is combined with Tocilizumab.
Flurazepam
The serum concentration of Flurazepam can be decreased when it is combined with Tocilizumab.
Flutamide
The serum concentration of Flutamide can be decreased when it is combined with Tocilizumab.
Fluticasone Furoate
The serum concentration of Fluticasone furoate can be decreased when it is combined with Tocilizumab.
Fluticasone propionate
The serum concentration of Fluticasone propionate can be decreased when it is combined with Tocilizumab.
Fluvastatin
The serum concentration of Fluvastatin can be decreased when it is combined with Tocilizumab.
Fosamprenavir
The serum concentration of Fosamprenavir can be decreased when it is combined with Tocilizumab.
Fosnetupitant
The serum concentration of Fosnetupitant can be decreased when it is combined with Tocilizumab.
Fostamatinib
The serum concentration of Fostamatinib can be decreased when it is combined with Tocilizumab.
Fulvestrant
The serum concentration of Fulvestrant can be decreased when it is combined with Tocilizumab.
Galantamine
The serum concentration of Galantamine can be decreased when it is combined with Tocilizumab.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Tocilizumab.
Gemfibrozil
The serum concentration of Gemfibrozil can be decreased when it is combined with Tocilizumab.
Glipizide
The serum concentration of Glipizide can be decreased when it is combined with Tocilizumab.
Glyburide
The serum concentration of Glyburide can be decreased when it is combined with Tocilizumab.
Golimumab
Tocilizumab may increase the immunosuppressive activities of Golimumab.
Granisetron
The serum concentration of Granisetron can be decreased when it is combined with Tocilizumab.
Grazoprevir
The serum concentration of Grazoprevir can be decreased when it is combined with Tocilizumab.
Grazoprevir anhydrous
The serum concentration of Grazoprevir can be decreased when it is combined with Tocilizumab.
Grepafloxacin
The serum concentration of Grepafloxacin can be decreased when it is combined with Tocilizumab.
Guanfacine
The serum concentration of Guanfacine can be decreased when it is combined with Tocilizumab.
Halofantrine
The serum concentration of Halofantrine can be decreased when it is combined with Tocilizumab.
Haloperidol
The serum concentration of Haloperidol can be decreased when it is combined with Tocilizumab.
Halothane
The serum concentration of Halothane can be decreased when it is combined with Tocilizumab.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Hepatitis B Vaccine (Recombinant).
Hexobarbital
The serum concentration of Hexobarbital can be decreased when it is combined with Tocilizumab.
Histamine
The serum concentration of Histamine can be decreased when it is combined with Tocilizumab.
Hydrocodone
The serum concentration of Hydrocodone can be decreased when it is combined with Tocilizumab.
HYDROCODONE POLISTIREX
The serum concentration of Hydrocodone can be decreased when it is combined with Tocilizumab.
Hydrocortisone
The serum concentration of Hydrocortisone can be decreased when it is combined with Tocilizumab.
Hydromorphone
The serum concentration of Hydromorphone can be decreased when it is combined with Tocilizumab.
hydroxyprogesterone caproate (USP)
The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Tocilizumab.
Ibrutinib
The serum concentration of Ibrutinib can be decreased when it is combined with Tocilizumab.
Ifosfamide
The serum concentration of Ifosfamide can be decreased when it is combined with Tocilizumab.
Iloperidone
The serum concentration of Iloperidone can be decreased when it is combined with Tocilizumab.
Imatinib
The serum concentration of Imatinib can be decreased when it is combined with Tocilizumab.
Imipramine
The serum concentration of Imipramine can be decreased when it is combined with Tocilizumab.
Imiquimod
The serum concentration of Imiquimod can be decreased when it is combined with Tocilizumab.
Indacaterol
The serum concentration of Indacaterol can be decreased when it is combined with Tocilizumab.
Indapamide
The serum concentration of Indapamide can be decreased when it is combined with Tocilizumab.
Indinavir
The serum concentration of Indinavir can be decreased when it is combined with Tocilizumab.
INDINAVIR ANHYDROUS
The serum concentration of Indinavir can be decreased when it is combined with Tocilizumab.
Infliximab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Infliximab.
Infliximab-Abda
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Infliximab.
Infliximab-Dyyb
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Infliximab.
Ipecac
The serum concentration of Ipecac can be decreased when it is combined with Tocilizumab.
Ipratropium
The serum concentration of Ipratropium bromide can be decreased when it is combined with Tocilizumab.
Ipratropium cation
The serum concentration of Ipratropium bromide can be decreased when it is combined with Tocilizumab.
Irinotecan
The serum concentration of Irinotecan can be decreased when it is combined with Tocilizumab.
Isavuconazole
The serum concentration of Isavuconazole can be decreased when it is combined with Tocilizumab.
Isavuconazonium
The serum concentration of Isavuconazonium can be decreased when it is combined with Tocilizumab.
Isosorbide Dinitrate
The serum concentration of Isosorbide Dinitrate can be decreased when it is combined with Tocilizumab.
Isosorbide Mononitrate
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Tocilizumab.
Isradipine
The serum concentration of Isradipine can be decreased when it is combined with Tocilizumab.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Tocilizumab.
Ivabradine
The serum concentration of Ivabradine can be decreased when it is combined with Tocilizumab.
Ivacaftor
The serum concentration of Ivacaftor can be decreased when it is combined with Tocilizumab.
Ivermectin
The serum concentration of Ivermectin can be decreased when it is combined with Tocilizumab.
Ixabepilone
The serum concentration of Ixabepilone can be decreased when it is combined with Tocilizumab.
Ixazomib
The serum concentration of Ixazomib can be decreased when it is combined with Tocilizumab.
Ketamine
The serum concentration of Ketamine can be decreased when it is combined with Tocilizumab.
Ketazolam
The serum concentration of Ketazolam can be decreased when it is combined with Tocilizumab.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Tocilizumab.
Lacidipine
The serum concentration of Lacidipine can be decreased when it is combined with Tocilizumab.
Lansoprazole
The serum concentration of Lansoprazole can be decreased when it is combined with Tocilizumab.
Lapatinib
The serum concentration of Lapatinib can be decreased when it is combined with Tocilizumab.
Leflunomide
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Leflunomide.
Lenvatinib
The serum concentration of Lenvatinib can be decreased when it is combined with Tocilizumab.
Lenvatinib Mesylate
The serum concentration of Lenvatinib can be decreased when it is combined with Tocilizumab.
Lercanidipine
The serum concentration of Lercanidipine can be decreased when it is combined with Tocilizumab.
Letrozole
The serum concentration of Letrozole can be decreased when it is combined with Tocilizumab.
Levobupivacaine
The serum concentration of Levobupivacaine can be decreased when it is combined with Tocilizumab.
Levocetirizine
The serum concentration of Levocetirizine can be decreased when it is combined with Tocilizumab.
Levomethadyl
The serum concentration of Levomethadyl Acetate can be decreased when it is combined with Tocilizumab.
Levomilnacipran
The serum concentration of Levomilnacipran can be decreased when it is combined with Tocilizumab.
Levonorgestrel
The serum concentration of Levonorgestrel can be decreased when it is combined with Tocilizumab.
Levothyroxine
The serum concentration of Levothyroxine can be decreased when it is combined with Tocilizumab.
Lidocaine
The serum concentration of Lidocaine can be decreased when it is combined with Tocilizumab.
Lisuride
The serum concentration of Lisuride can be decreased when it is combined with Tocilizumab.
Lomitapide
The serum concentration of Lomitapide can be decreased when it is combined with Tocilizumab.
Loperamide
The serum concentration of Loperamide can be decreased when it is combined with Tocilizumab.
Lopinavir
The serum concentration of Lopinavir can be decreased when it is combined with Tocilizumab.
Loratadine
The serum concentration of Loratadine can be decreased when it is combined with Tocilizumab.
Lorcaserin
The serum concentration of Lorcaserin can be decreased when it is combined with Tocilizumab.
Losartan
The serum concentration of Losartan can be decreased when it is combined with Tocilizumab.
Lovastatin
The serum concentration of Lovastatin can be decreased when it is combined with Tocilizumab.
Lumefantrine
The serum concentration of Lumefantrine can be decreased when it is combined with Tocilizumab.
Lurasidone
The serum concentration of Lurasidone can be decreased when it is combined with Tocilizumab.
Macimorelin
The serum concentration of Macimorelin can be decreased when it is combined with Tocilizumab.
Macitentan
The serum concentration of Macitentan can be decreased when it is combined with Tocilizumab.
Maraviroc
The serum concentration of Maraviroc can be decreased when it is combined with Tocilizumab.
Mebendazole
The serum concentration of Mebendazole can be decreased when it is combined with Tocilizumab.
Medroxyprogesterone Acetate
The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Tocilizumab.
Mefloquine
The serum concentration of Mefloquine can be decreased when it is combined with Tocilizumab.
Meloxicam
The serum concentration of Meloxicam can be decreased when it is combined with Tocilizumab.
Meperidine
The serum concentration of Pethidine can be decreased when it is combined with Tocilizumab.
Methadone
The serum concentration of Methadone can be decreased when it is combined with Tocilizumab.
Methaqualone
The serum concentration of Methaqualone can be decreased when it is combined with Tocilizumab.
Methoxsalen
The serum concentration of Methoxsalen can be decreased when it is combined with Tocilizumab.
Methoxyflurane
The serum concentration of Methoxyflurane can be decreased when it is combined with Tocilizumab.
Methylprednisolone
The serum concentration of Methylprednisolone can be decreased when it is combined with Tocilizumab.
Methyltestosterone
The serum concentration of Methyltestosterone can be decreased when it is combined with Tocilizumab.
Metronidazole
The serum concentration of Metronidazole can be decreased when it is combined with Tocilizumab.
Mexiletine
The serum concentration of Mexiletine can be decreased when it is combined with Tocilizumab.
Mianserin
The serum concentration of Mianserin can be decreased when it is combined with Tocilizumab.
Mibefradil
The serum concentration of Mibefradil can be decreased when it is combined with Tocilizumab.
Miconazole
The serum concentration of Miconazole can be decreased when it is combined with Tocilizumab.
Midazolam
The serum concentration of Midazolam can be decreased when it is combined with Tocilizumab.
Midecamycin
The serum concentration of Midecamycin can be decreased when it is combined with Tocilizumab.
Midostaurin
The serum concentration of Midostaurin can be decreased when it is combined with Tocilizumab.
Mifepristone
The serum concentration of Mifepristone can be decreased when it is combined with Tocilizumab.
Mirabegron
The serum concentration of Mirabegron can be decreased when it is combined with Tocilizumab.
Mirtazapine
The serum concentration of Mirtazapine can be decreased when it is combined with Tocilizumab.
Modafinil
The serum concentration of Modafinil can be decreased when it is combined with Tocilizumab.
Montelukast
The serum concentration of Montelukast can be decreased when it is combined with Tocilizumab.
Morphine
The serum concentration of Morphine can be decreased when it is combined with Tocilizumab.
Mycophenolate Mofetil
The serum concentration of Mycophenolate mofetil can be decreased when it is combined with Tocilizumab.
Naloxegol
The serum concentration of Naloxegol can be decreased when it is combined with Tocilizumab.
Naloxone
The serum concentration of Naloxone can be decreased when it is combined with Tocilizumab.
Natalizumab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Natalizumab.
Nateglinide
The serum concentration of Nateglinide can be decreased when it is combined with Tocilizumab.
Nefazodone
The serum concentration of Nefazodone can be decreased when it is combined with Tocilizumab.
Nelfinavir
The serum concentration of Nelfinavir can be decreased when it is combined with Tocilizumab.
Neratinib
The serum concentration of Neratinib can be decreased when it is combined with Tocilizumab.
Nevirapine
The serum concentration of Nevirapine can be decreased when it is combined with Tocilizumab.
Nicardipine
The serum concentration of Nicardipine can be decreased when it is combined with Tocilizumab.
Nicotine
The serum concentration of Nicotine can be decreased when it is combined with Tocilizumab.
Nicotine Polacrilex
The serum concentration of Nicotine can be decreased when it is combined with Tocilizumab.
Nifedipine
The serum concentration of Nifedipine can be decreased when it is combined with Tocilizumab.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Tocilizumab.
Nilvadipine
The serum concentration of Nilvadipine can be decreased when it is combined with Tocilizumab.
Nimodipine
The serum concentration of Nimodipine can be decreased when it is combined with Tocilizumab.
Nisoldipine
The serum concentration of Nisoldipine can be decreased when it is combined with Tocilizumab.
Nitrazepam
The serum concentration of Nitrazepam can be decreased when it is combined with Tocilizumab.
Nitrendipine
The serum concentration of Nitrendipine can be decreased when it is combined with Tocilizumab.
Norethindrone
The serum concentration of Norethisterone can be decreased when it is combined with Tocilizumab.
Norgestrel
The serum concentration of Norgestrel can be decreased when it is combined with Tocilizumab.
Nortriptyline
The serum concentration of Nortriptyline can be decreased when it is combined with Tocilizumab.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Tocilizumab.
Olaparib
The serum concentration of Olaparib can be decreased when it is combined with Tocilizumab.
Olopatadine
The serum concentration of Olopatadine can be decreased when it is combined with Tocilizumab.
Omeprazole
The serum concentration of Omeprazole can be decreased when it is combined with Tocilizumab.
Ondansetron
The serum concentration of Ondansetron can be decreased when it is combined with Tocilizumab.
Opium
The serum concentration of Opium can be decreased when it is combined with Tocilizumab.
Orphenadrine
The serum concentration of Orphenadrine can be decreased when it is combined with Tocilizumab.
Ospemifene
The serum concentration of Ospemifene can be decreased when it is combined with Tocilizumab.
Oxazepam
The serum concentration of Oxazepam can be decreased when it is combined with Tocilizumab.
Oxybutynin
The serum concentration of Oxybutynin can be decreased when it is combined with Tocilizumab.
Oxycodone
The serum concentration of Oxycodone can be decreased when it is combined with Tocilizumab.
Oxymorphone
The serum concentration of Oxymorphone can be decreased when it is combined with Tocilizumab.
Paclitaxel
The serum concentration of Paclitaxel can be decreased when it is combined with Tocilizumab.
Palbociclib
The serum concentration of Palbociclib can be decreased when it is combined with Tocilizumab.
Palonosetron
The serum concentration of Palonosetron can be decreased when it is combined with Tocilizumab.
Panobinostat
The serum concentration of Panobinostat can be decreased when it is combined with Tocilizumab.
Pantoprazole
The serum concentration of Pantoprazole can be decreased when it is combined with Tocilizumab.
Paramethadione
The serum concentration of Paramethadione can be decreased when it is combined with Tocilizumab.
Paramethasone
The serum concentration of Paramethasone can be decreased when it is combined with Tocilizumab.
Parecoxib
The serum concentration of Parecoxib can be decreased when it is combined with Tocilizumab.
Paregoric
The serum concentration of Morphine can be decreased when it is combined with Tocilizumab.
Paricalcitol
The serum concentration of Paricalcitol can be decreased when it is combined with Tocilizumab.
Paritaprevir
The serum concentration of Paritaprevir can be decreased when it is combined with Tocilizumab.
Pazopanib
The serum concentration of Pazopanib can be decreased when it is combined with Tocilizumab.
Pentamidine
The serum concentration of Pentamidine can be decreased when it is combined with Tocilizumab.
Perampanel
The serum concentration of Perampanel can be decreased when it is combined with Tocilizumab.
Pergolide
The serum concentration of Pergolide can be decreased when it is combined with Tocilizumab.
Perhexiline
The serum concentration of Perhexiline can be decreased when it is combined with Tocilizumab.
Permethrin
The serum concentration of Permethrin can be decreased when it is combined with Tocilizumab.
Perphenazine
The serum concentration of Perphenazine can be decreased when it is combined with Tocilizumab.
Phenacetin
The serum concentration of Phenacetin can be decreased when it is combined with Tocilizumab.
Phenoxybenzamine
The serum concentration of Phenoxybenzamine can be decreased when it is combined with Tocilizumab.
Phenprocoumon
The serum concentration of Phenprocoumon can be decreased when it is combined with Tocilizumab.
Phenytoin
The serum concentration of Phenytoin can be decreased when it is combined with Tocilizumab.
Pilocarpine
The serum concentration of Pilocarpine can be decreased when it is combined with Tocilizumab.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tocilizumab.
Pimozide
The serum concentration of Pimozide can be decreased when it is combined with Tocilizumab.
Pinacidil
The serum concentration of Pinacidil can be decreased when it is combined with Tocilizumab.
Pioglitazone
The serum concentration of Pioglitazone can be decreased when it is combined with Tocilizumab.
Pipothiazine
The serum concentration of Pipotiazine can be decreased when it is combined with Tocilizumab.
Pirfenidone
Tocilizumab may increase the immunosuppressive activities of Pirfenidone.
Podofilox
The serum concentration of Podofilox can be decreased when it is combined with Tocilizumab.
Pomalidomide
The serum concentration of Pomalidomide can be decreased when it is combined with Tocilizumab.
Ponatinib
The serum concentration of Ponatinib can be decreased when it is combined with Tocilizumab.
Posaconazole
The serum concentration of Posaconazole can be decreased when it is combined with Tocilizumab.
Prasterone
The serum concentration of Prasterone can be decreased when it is combined with Tocilizumab.
Prasugrel
The serum concentration of Prasugrel can be decreased when it is combined with Tocilizumab.
Pravastatin
The serum concentration of Pravastatin can be decreased when it is combined with Tocilizumab.
Prazepam
The serum concentration of Prazepam can be decreased when it is combined with Tocilizumab.
Praziquantel
The serum concentration of Praziquantel can be decreased when it is combined with Tocilizumab.
Prednisolone
The serum concentration of Prednisolone can be decreased when it is combined with Tocilizumab.
Prednisone
The serum concentration of Prednisone can be decreased when it is combined with Tocilizumab.
Primaquine
The serum concentration of Primaquine can be decreased when it is combined with Tocilizumab.
Prochlorperazine
The serum concentration of Prochlorperazine can be decreased when it is combined with Tocilizumab.
Progesterone
The serum concentration of Progesterone can be decreased when it is combined with Tocilizumab.
Proguanil
The serum concentration of Proguanil can be decreased when it is combined with Tocilizumab.
Promazine
The serum concentration of Promazine can be decreased when it is combined with Tocilizumab.
Propafenone
The serum concentration of Propafenone can be decreased when it is combined with Tocilizumab.
Propiverine
The serum concentration of Propiverine can be decreased when it is combined with Tocilizumab.
Propofol
The serum concentration of Propofol can be decreased when it is combined with Tocilizumab.
Propoxyphene
The serum concentration of Dextropropoxyphene can be decreased when it is combined with Tocilizumab.
Propranolol
The serum concentration of Propranolol can be decreased when it is combined with Tocilizumab.
Pyrazinamide
The serum concentration of Pyrazinamide can be decreased when it is combined with Tocilizumab.
Quazepam
The serum concentration of Quazepam can be decreased when it is combined with Tocilizumab.
Quetiapine
The serum concentration of Quetiapine can be decreased when it is combined with Tocilizumab.
Quetiapine fumarate
The serum concentration of Quetiapine can be decreased when it is combined with Tocilizumab.
Quinacrine
The serum concentration of Quinacrine can be decreased when it is combined with Tocilizumab.
Quinidine
The serum concentration of Quinidine can be decreased when it is combined with Tocilizumab.
Quinine
The serum concentration of Quinine can be decreased when it is combined with Tocilizumab.
Rabeprazole
The serum concentration of Rabeprazole can be decreased when it is combined with Tocilizumab.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Rabies virus inactivated antigen, A.
Raloxifene
The serum concentration of Raloxifene can be decreased when it is combined with Tocilizumab.
Ramelteon
The serum concentration of Ramelteon can be decreased when it is combined with Tocilizumab.
Ranolazine
The serum concentration of Ranolazine can be decreased when it is combined with Tocilizumab.
Reboxetine
The serum concentration of Reboxetine can be decreased when it is combined with Tocilizumab.
Regorafenib
The serum concentration of Regorafenib can be decreased when it is combined with Tocilizumab.
Repaglinide
The serum concentration of Repaglinide can be decreased when it is combined with Tocilizumab.
Retapamulin
The serum concentration of Retapamulin can be decreased when it is combined with Tocilizumab.
Rifabutin
The serum concentration of Rifabutin can be decreased when it is combined with Tocilizumab.
Rifampin
The serum concentration of Rifampicin can be decreased when it is combined with Tocilizumab.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Tocilizumab.
Riociguat
The serum concentration of Riociguat can be decreased when it is combined with Tocilizumab.
Risperidone
The serum concentration of Risperidone can be decreased when it is combined with Tocilizumab.
Ritonavir
The serum concentration of Ritonavir can be decreased when it is combined with Tocilizumab.
Rituximab
The risk or severity of adverse effects can be increased when Rituximab is combined with Tocilizumab.
Rivaroxaban
The serum concentration of Rivaroxaban can be decreased when it is combined with Tocilizumab.
Rofecoxib
The serum concentration of Rofecoxib can be decreased when it is combined with Tocilizumab.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Tocilizumab.
Rolapitant
The serum concentration of Rolapitant can be decreased when it is combined with Tocilizumab.
Romidepsin
The serum concentration of Romidepsin can be decreased when it is combined with Tocilizumab.
Ropinirole
The serum concentration of Ropinirole can be decreased when it is combined with Tocilizumab.
Ropivacaine
The serum concentration of Ropivacaine can be decreased when it is combined with Tocilizumab.
Rosuvastatin
The serum concentration of Rosuvastatin can be decreased when it is combined with Tocilizumab.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Rotavirus Vaccine.
Rotigotine
The serum concentration of Rotigotine can be decreased when it is combined with Tocilizumab.
Roxithromycin
The serum concentration of Roxithromycin can be decreased when it is combined with Tocilizumab.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Rubella virus vaccine.
Rucaparib
The serum concentration of Rucaparib can be decreased when it is combined with Tocilizumab.
Ruxolitinib
The serum concentration of Ruxolitinib can be decreased when it is combined with Tocilizumab.
Safinamide
The serum concentration of Safinamide can be decreased when it is combined with Tocilizumab.
Salmeterol
The serum concentration of Salmeterol can be decreased when it is combined with Tocilizumab.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Salmonella typhi ty21a live antigen.
Saquinavir
The serum concentration of Saquinavir can be decreased when it is combined with Tocilizumab.
Saquinavir Mesylate
The serum concentration of Saquinavir can be decreased when it is combined with Tocilizumab.
Saxagliptin
The serum concentration of Saxagliptin can be decreased when it is combined with Tocilizumab.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be decreased when it is combined with Tocilizumab.
Selegiline
The serum concentration of Selegiline can be decreased when it is combined with Tocilizumab.
Selexipag
The serum concentration of Selexipag can be decreased when it is combined with Tocilizumab.
Sertindole
The serum concentration of Sertindole can be decreased when it is combined with Tocilizumab.
Sertraline
The serum concentration of Sertraline can be decreased when it is combined with Tocilizumab.
Sevoflurane
The serum concentration of Sevoflurane can be decreased when it is combined with Tocilizumab.
Sibutramine
The serum concentration of Sibutramine can be decreased when it is combined with Tocilizumab.
Sildenafil
The serum concentration of Sildenafil can be decreased when it is combined with Tocilizumab.
Silodosin
The serum concentration of Silodosin can be decreased when it is combined with Tocilizumab.
Simvastatin
The serum concentration of Simvastatin can be decreased when it is combined with Tocilizumab.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Tocilizumab.
Sirolimus
The serum concentration of Sirolimus can be decreased when it is combined with Tocilizumab.
Sitagliptin
The serum concentration of Sitagliptin can be decreased when it is combined with Tocilizumab.
Sitagliptin Phosphate
The serum concentration of Sitagliptin can be decreased when it is combined with Tocilizumab.
Solifenacin
The serum concentration of Solifenacin can be decreased when it is combined with Tocilizumab.
Sonidegib
The serum concentration of Sonidegib can be decreased when it is combined with Tocilizumab.
Sorafenib
The serum concentration of Sorafenib can be decreased when it is combined with Tocilizumab.
Spiramycin
The serum concentration of Spiramycin can be decreased when it is combined with Tocilizumab.
Sufentanil
The serum concentration of Sufentanil can be decreased when it is combined with Tocilizumab.
Sulfadiazine
The serum concentration of Sulfadiazine can be decreased when it is combined with Tocilizumab.
Sulfamethoxazole
The serum concentration of Sulfamethoxazole can be decreased when it is combined with Tocilizumab.
Sulfinpyrazone
The serum concentration of Sulfinpyrazone can be decreased when it is combined with Tocilizumab.
Sunitinib
The serum concentration of Sunitinib can be decreased when it is combined with Tocilizumab.
synthetic conjugated estrogens, A
The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Tocilizumab.
synthetic conjugated estrogens, B
The serum concentration of Synthetic Conjugated Estrogens, B can be decreased when it is combined with Tocilizumab.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Tocilizumab.
Tadalafil
The serum concentration of Tadalafil can be decreased when it is combined with Tocilizumab.
Tamoxifen
The serum concentration of Tamoxifen can be decreased when it is combined with Tocilizumab.
Tamsulosin
The serum concentration of Tamsulosin can be decreased when it is combined with Tocilizumab.
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with Tocilizumab.
Telithromycin
The serum concentration of Telithromycin can be decreased when it is combined with Tocilizumab.
Temazepam
The serum concentration of Temazepam can be decreased when it is combined with Tocilizumab.
Temsirolimus
The serum concentration of Temsirolimus can be decreased when it is combined with Tocilizumab.
Teniposide
The serum concentration of Teniposide can be decreased when it is combined with Tocilizumab.
Terbinafine
The serum concentration of Terbinafine can be decreased when it is combined with Tocilizumab.
Terfenadine
The serum concentration of Terfenadine can be decreased when it is combined with Tocilizumab.
Testosterone
The serum concentration of Testosterone can be decreased when it is combined with Tocilizumab.
Testosterone Cypionate
The serum concentration of Testosterone cypionate can be decreased when it is combined with Tocilizumab.
Testosterone Enanthate
The serum concentration of Testosterone enanthate can be decreased when it is combined with Tocilizumab.
Testosterone Propionate
The serum concentration of Testosterone propionate can be decreased when it is combined with Tocilizumab.
Testosterone Undecanoate
The serum concentration of Testosterone undecanoate can be decreased when it is combined with Tocilizumab.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tetracycline
The serum concentration of Tetracycline can be decreased when it is combined with Tocilizumab.
Tetrahydrocannabinol
The serum concentration of Dronabinol can be decreased when it is combined with Tocilizumab.
Tezacaftor
The serum concentration of Tezacaftor can be decreased when it is combined with Tocilizumab.
Theophylline
The serum concentration of Theophylline can be decreased when it is combined with Tocilizumab.
Theophylline anhydrous
The serum concentration of Theophylline can be decreased when it is combined with Tocilizumab.
Thiotepa
The serum concentration of Thiotepa can be decreased when it is combined with Tocilizumab.
Tiagabine
The serum concentration of Tiagabine can be decreased when it is combined with Tocilizumab.
Ticagrelor
The serum concentration of Ticagrelor can be decreased when it is combined with Tocilizumab.
Ticlopidine
The serum concentration of Ticlopidine can be decreased when it is combined with Tocilizumab.
Tinidazole
The serum concentration of Tinidazole can be decreased when it is combined with Tocilizumab.
Tiotropium
The serum concentration of Tiotropium can be decreased when it is combined with Tocilizumab.
Tipranavir
The serum concentration of Tipranavir can be decreased when it is combined with Tocilizumab.
Tocopherol
The serum concentration of Tocopherol can be decreased when it is combined with Tocilizumab.
Tocopherol Acetate
The serum concentration of alpha-Tocopherol acetate can be decreased when it is combined with Tocilizumab.
Tocophersolan
The serum concentration of Tocofersolan can be decreased when it is combined with Tocilizumab.
Tofacitinib
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Tofacitinib.
Tolterodine
The serum concentration of Tolterodine can be decreased when it is combined with Tocilizumab.
Tolvaptan
The serum concentration of Tolvaptan can be decreased when it is combined with Tocilizumab.
Toremifene
The serum concentration of Toremifene can be decreased when it is combined with Tocilizumab.
Trabectedin
The serum concentration of Trabectedin can be decreased when it is combined with Tocilizumab.
Tramadol
The serum concentration of Tramadol can be decreased when it is combined with Tocilizumab.
Trastuzumab
Trastuzumab may increase the neutropenic activities of Tocilizumab.
Trazodone
The serum concentration of Trazodone can be decreased when it is combined with Tocilizumab.
Tretinoin
The serum concentration of Tretinoin can be decreased when it is combined with Tocilizumab.
Triamcinolone
The serum concentration of Triamcinolone can be decreased when it is combined with Tocilizumab.
Triazolam
The serum concentration of Triazolam can be decreased when it is combined with Tocilizumab.
Trimethadione
The serum concentration of Trimethadione can be decreased when it is combined with Tocilizumab.
Trimethoprim
The serum concentration of Trimethoprim can be decreased when it is combined with Tocilizumab.
Trimipramine
The serum concentration of Trimipramine can be decreased when it is combined with Tocilizumab.
Troglitazone
The serum concentration of Troglitazone can be decreased when it is combined with Tocilizumab.
Troleandomycin
The serum concentration of Troleandomycin can be decreased when it is combined with Tocilizumab.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Ulipristal
The serum concentration of Ulipristal can be decreased when it is combined with Tocilizumab.
Valbenazine
The serum concentration of Valbenazine can be decreased when it is combined with Tocilizumab.
Valdecoxib
The serum concentration of Valdecoxib can be decreased when it is combined with Tocilizumab.
Vandetanib
The serum concentration of Vandetanib can be decreased when it is combined with Tocilizumab.
Vardenafil
The serum concentration of Vardenafil can be decreased when it is combined with Tocilizumab.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Varicella Zoster Vaccine (Live/Attenuated).
Velpatasvir
The serum concentration of Velpatasvir can be decreased when it is combined with Tocilizumab.
Vemurafenib
The serum concentration of Vemurafenib can be decreased when it is combined with Tocilizumab.
Venetoclax
The serum concentration of Venetoclax can be decreased when it is combined with Tocilizumab.
Venlafaxine
The serum concentration of Venlafaxine can be decreased when it is combined with Tocilizumab.
Verapamil
The serum concentration of Verapamil can be decreased when it is combined with Tocilizumab.
Vilanterol
The serum concentration of Vilanterol can be decreased when it is combined with Tocilizumab.
Vilazodone
The serum concentration of Vilazodone can be decreased when it is combined with Tocilizumab.
Vinblastine
The serum concentration of Vinblastine can be decreased when it is combined with Tocilizumab.
Vincristine
The serum concentration of Vincristine can be decreased when it is combined with Tocilizumab.
Vindesine
The serum concentration of Vindesine can be decreased when it is combined with Tocilizumab.
Vinorelbine
The serum concentration of Vinorelbine can be decreased when it is combined with Tocilizumab.
Vismodegib
The serum concentration of Vismodegib can be decreased when it is combined with Tocilizumab.
vitamine E acetate
The serum concentration of alpha-Tocopherol acetate can be decreased when it is combined with Tocilizumab.
Voriconazole
The serum concentration of Voriconazole can be decreased when it is combined with Tocilizumab.
Vortioxetine
The serum concentration of Vortioxetine can be decreased when it is combined with Tocilizumab.
Voxilaprevir
The serum concentration of Voxilaprevir can be decreased when it is combined with Tocilizumab.
Warfarin
The serum concentration of Warfarin can be decreased when it is combined with Tocilizumab.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Yellow Fever Vaccine.
Yohimbine
The serum concentration of Yohimbine can be decreased when it is combined with Tocilizumab.
Zafirlukast
The serum concentration of Zafirlukast can be decreased when it is combined with Tocilizumab.
Zalcitabine
The serum concentration of Zalcitabine can be decreased when it is combined with Tocilizumab.
Zaleplon
The serum concentration of Zaleplon can be decreased when it is combined with Tocilizumab.
Zidovudine
The serum concentration of Zidovudine can be decreased when it is combined with Tocilizumab.
Zileuton
The serum concentration of Zileuton can be decreased when it is combined with Tocilizumab.
Ziprasidone
The serum concentration of Ziprasidone can be decreased when it is combined with Tocilizumab.
Zolpidem
The serum concentration of Zolpidem can be decreased when it is combined with Tocilizumab.
Zomepirac
The serum concentration of Zomepirac can be decreased when it is combined with Tocilizumab.
Zonisamide
The serum concentration of Zonisamide can be decreased when it is combined with Tocilizumab.
Zopiclone
The serum concentration of Zopiclone can be decreased when it is combined with Tocilizumab.
Zotepine
The serum concentration of Zotepine can be decreased when it is combined with Tocilizumab.
